Matches in Nanopublications for { ?s ?p "[However, no significant associations were found between XPD Lys751Gln polymorphism and EC risk when all studies pooled into the meta-analysis (Lys/Gln vs. Lys/Lys: OR 1.07, 95% CI = 0.88-1.28; Gln/Gln vs.us Lys/Lys: OR 1.25, 95% CI = 0.92-1.71; dominant model: OR 1.09, 95% CI = 0.90-1.33).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP744279.RAj6jLc8HzH35kTW7TV_5HawvwFcCQDjp60bA6qhhT-Ec130_assertion description "[However, no significant associations were found between XPD Lys751Gln polymorphism and EC risk when all studies pooled into the meta-analysis (Lys/Gln vs. Lys/Lys: OR 1.07, 95% CI = 0.88-1.28; Gln/Gln vs.us Lys/Lys: OR 1.25, 95% CI = 0.92-1.71; dominant model: OR 1.09, 95% CI = 0.90-1.33).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP744279.RAj6jLc8HzH35kTW7TV_5HawvwFcCQDjp60bA6qhhT-Ec130_provenance.
- NP505554.RAfkZm0WB6I5lzz2z2DUyBEtYsGJWv-amX1KCaiWO810k130_assertion description "[However, no significant associations were found between XPD Lys751Gln polymorphism and EC risk when all studies pooled into the meta-analysis (Lys/Gln vs. Lys/Lys: OR 1.07, 95% CI = 0.88-1.28; Gln/Gln vs.us Lys/Lys: OR 1.25, 95% CI = 0.92-1.71; dominant model: OR 1.09, 95% CI = 0.90-1.33).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505554.RAfkZm0WB6I5lzz2z2DUyBEtYsGJWv-amX1KCaiWO810k130_provenance.
- NP841305.RASmS46-CSpyBzVvfQT7PCfgTGZwcglwy6RGK75kTNpeg130_assertion description "[However, no significant associations were found between XPD Lys751Gln polymorphism and EC risk when all studies pooled into the meta-analysis (Lys/Gln vs. Lys/Lys: OR 1.07, 95% CI = 0.88-1.28; Gln/Gln vs.us Lys/Lys: OR 1.25, 95% CI = 0.92-1.71; dominant model: OR 1.09, 95% CI = 0.90-1.33).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841305.RASmS46-CSpyBzVvfQT7PCfgTGZwcglwy6RGK75kTNpeg130_provenance.
- NP584132.RAfZsJj8Ag4ykYWNyKYg3lYLHEicyR5pilQYRnVOIx420130_assertion description "[However, no significant associations were found between XPD Lys751Gln polymorphism and EC risk when all studies pooled into the meta-analysis (Lys/Gln vs. Lys/Lys: OR 1.07, 95% CI = 0.88-1.28; Gln/Gln vs.us Lys/Lys: OR 1.25, 95% CI = 0.92-1.71; dominant model: OR 1.09, 95% CI = 0.90-1.33).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584132.RAfZsJj8Ag4ykYWNyKYg3lYLHEicyR5pilQYRnVOIx420130_provenance.
- NP789646.RAdyaK9JILpiZETkA2SFvXwxX2pOxHm3Y1nHNWTBa44gw130_assertion description "[However, no significant associations were found between XPD Lys751Gln polymorphism and EC risk when all studies pooled into the meta-analysis (Lys/Gln vs. Lys/Lys: OR 1.07, 95% CI = 0.88-1.28; Gln/Gln vs.us Lys/Lys: OR 1.25, 95% CI = 0.92-1.71; dominant model: OR 1.09, 95% CI = 0.90-1.33).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789646.RAdyaK9JILpiZETkA2SFvXwxX2pOxHm3Y1nHNWTBa44gw130_provenance.
- NP405426.RA6IkQEh1DLgATMxOMkGv7gsE5Ptz2d73Ah8xvs0rDFaY130_assertion description "[However, no significant associations were found between XPD Lys751Gln polymorphism and EC risk when all studies pooled into the meta-analysis (Lys/Gln vs. Lys/Lys: OR 1.07, 95% CI = 0.88-1.28; Gln/Gln vs.us Lys/Lys: OR 1.25, 95% CI = 0.92-1.71; dominant model: OR 1.09, 95% CI = 0.90-1.33).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405426.RA6IkQEh1DLgATMxOMkGv7gsE5Ptz2d73Ah8xvs0rDFaY130_provenance.
- NP762861.RA1LEWrdoc3bIUD4mYLSDPomHTjMAhvpwfc32JJQjOJns130_assertion description "[However, no significant associations were found between XPD Lys751Gln polymorphism and EC risk when all studies pooled into the meta-analysis (Lys/Gln vs. Lys/Lys: OR 1.07, 95% CI = 0.88-1.28; Gln/Gln vs.us Lys/Lys: OR 1.25, 95% CI = 0.92-1.71; dominant model: OR 1.09, 95% CI = 0.90-1.33).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP762861.RA1LEWrdoc3bIUD4mYLSDPomHTjMAhvpwfc32JJQjOJns130_provenance.
- NP487214.RAO8wfLpsFhlGEhUtuZnFi105I4edT9NKrIJof2hiPE14130_assertion description "[However, no significant associations were found between XPD Lys751Gln polymorphism and EC risk when all studies pooled into the meta-analysis (Lys/Gln vs. Lys/Lys: OR 1.07, 95% CI = 0.88-1.28; Gln/Gln vs.us Lys/Lys: OR 1.25, 95% CI = 0.92-1.71; dominant model: OR 1.09, 95% CI = 0.90-1.33).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487214.RAO8wfLpsFhlGEhUtuZnFi105I4edT9NKrIJof2hiPE14130_provenance.